Dr. Sven Behrendt, Praxis für Knie und Schulterchirugie

The medical center is at the forefront of orthopedic research, particularly in the area of meniscal replacement. The ongoing study on sterile allogeneic spongioflex® allografts aims to enhance the functionality of the meniscus following incomplete meniscal loss. This research is pivotal in developing new surgical techniques and improving patient outcomes through comprehensive evaluations using Patient-Reported Outcome Measures (PROMs).

• Meniscal Replacement Techniques
• Patient-Reported Outcome Measures (PROMs)
• Long-term Efficacy Studies

By comparing outcomes over a span of two to five years, the center contributes significantly to the understanding of long-term benefits and potential improvements in orthopedic procedures.

Specializing in oncology, the center is conducting a groundbreaking study on the treatment of Large-Cell NeuroEndocrine Carcinoma (LCNEC) of the lung. This research evaluates the efficacy and safety of combining durvalumab with etoposide and platinum-based therapies as a first-line treatment. The study is crucial for patients with locally advanced or metastatic LCNEC, offering new hope through innovative immunotherapy approaches.

• Combination Immunotherapy
• Advanced Lung Cancer Treatments
• Pathologist-Confirmed Diagnosis

Through this research, the center is advancing the field of oncology by exploring novel therapeutic combinations that could redefine treatment protocols for aggressive lung cancers.